These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E. Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043 [Abstract] [Full Text] [Related]
25. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D. Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [Abstract] [Full Text] [Related]
27. Influence of volumetric 4'-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients. Hoshikawa H, Mori T, Maeda Y, Takahashi S, Ouchi Y, Yamamoto Y, Nishiyama Y. Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399 [Abstract] [Full Text] [Related]
30. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer. Lee JW, Kang CM, Choi HJ, Lee WJ, Song SY, Lee JH, Lee JD. J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649 [Abstract] [Full Text] [Related]
31. The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study. Rufini V, Collarino A, Calcagni ML, Meduri GM, Fuoco V, Pasciuto T, Testa AC, Ferrandina G, Gambacorta MA, Campitelli M, Gui B, Zannoni G, Manfredi R, Scambia G, Giordano A. Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206 [Abstract] [Full Text] [Related]
37. Prognostic Value of the Volumetric Parameters of Dual-Time-Point 18F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy. Okazaki E, Seura H, Hasegawa Y, Okamura T, Fukuda H. AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426 [Abstract] [Full Text] [Related]
39. Prognostic significance of metabolic parameters measured by 18F-FDG PET/CT in limited-stage small-cell lung carcinoma. Chang H, Lee SJ, Lim J, Lee JS, Kim YJ, Lee WW. J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157 [Abstract] [Full Text] [Related]
40. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma]. Wu LL, Liang JH, Wang L, Xu W, Ding CY. Zhonghua Zhong Liu Za Zhi; 2019 Nov 23; 41(11):831-836. PubMed ID: 31770850 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]